Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
PFE

Pfizer

$35.36

-0.02 (-0.06%)

, NVS

Novartis

$82.60

-0.43 (-0.52%)

07:28
11/16/17
11/16
07:28
11/16/17
07:28
Periodicals
Pfizer, Novartis agree to UK price cuts for breast cancer drugs, Reuters reports »

Pfizer (PFE) and Novartis…

PFE

Pfizer

$35.36

-0.02 (-0.06%)

NVS

Novartis

$82.60

-0.43 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 30

    Nov

  • 04

    Dec

  • 06

    Dec

  • 09

    Dec

  • 14

    Dec

  • 17

    May

RHHBY

Roche

$28.73

-0.12 (-0.42%)

, ABBV

AbbVie

$93.76

-0.99 (-1.04%)

05:33
11/16/17
11/16
05:33
11/16/17
05:33
Recommendations
Roche, AbbVie, Novartis, Bayer, Johnson & Johnson, Zoetis, Eli Lilly, Merck, Novo Nordisk, AstraZeneca analyst commentary at Jefferies »

Jefferies names Roche new…

RHHBY

Roche

$28.73

-0.12 (-0.42%)

ABBV

AbbVie

$93.76

-0.99 (-1.04%)

NVS

Novartis

$82.60

-0.43 (-0.52%)

BAYRY

Bayer

$31.97

-0.04 (-0.12%)

JNJ

Johnson & Johnson

$139.10

-0.39 (-0.28%)

ZTS

Zoetis

$69.62

-0.28 (-0.40%)

LLY

Eli Lilly

$82.19

-0.3 (-0.36%)

MRK

Merck

$54.80

-0.19 (-0.35%)

NVO

Novo Nordisk

$49.67

-0.17 (-0.34%)

AZN

AstraZeneca

$33.39

0.14 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 16

    Nov

  • 16

    Nov

  • 28

    Nov

  • 30

    Nov

  • 30

    Nov

  • 30

    Nov

  • 04

    Dec

  • 06

    Dec

  • 09

    Dec

  • 14

    Dec

  • 23

    Dec

  • 02

    Feb

  • 23

    Feb

  • 17

    May

Monday
NVS

Novartis

$82.84

0.46 (0.56%)

12:03
11/13/17
11/13
12:03
11/13/17
12:03
Hot Stocks
Novartis canakinumab reduced CV risk by 25% in subgroup of CANTOS trial »

Novartis announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 30

    Nov

  • 04

    Dec

  • 06

    Dec

  • 09

    Dec

  • 17

    May

REGN

Regeneron

$404.54

-1.67 (-0.41%)

, NVS

Novartis

$82.38

-0.1 (-0.12%)

08:25
11/13/17
11/13
08:25
11/13/17
08:25
Recommendations
Regeneron, Novartis analyst commentary at Morgan Stanley »

Morgan Stanley sees…

REGN

Regeneron

$404.54

-1.67 (-0.41%)

NVS

Novartis

$82.38

-0.1 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 28

    Nov

  • 30

    Nov

  • 04

    Dec

  • 06

    Dec

  • 09

    Dec

  • 17

    May

REGN

Regeneron

$404.54

-1.67 (-0.41%)

, NVS

Novartis

$82.38

-0.1 (-0.12%)

06:14
11/13/17
11/13
06:14
11/13/17
06:14
Recommendations
Regeneron, Novartis analyst commentary at Piper Jaffray »

Piper says buy Regeneron…

REGN

Regeneron

$404.54

-1.67 (-0.41%)

NVS

Novartis

$82.38

-0.1 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 28

    Nov

  • 30

    Nov

  • 04

    Dec

  • 06

    Dec

  • 09

    Dec

  • 17

    May

NVS

Novartis

$82.38

-0.1 (-0.12%)

05:34
11/13/17
11/13
05:34
11/13/17
05:34
Hot Stocks
Novartis Access signs MoU with provincial government of Punjab in Pakistan »

The provincial government…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 30

    Nov

  • 04

    Dec

  • 06

    Dec

  • 09

    Dec

  • 17

    May

Sunday
CRIS

Curis

$1.23

-0.12 (-8.89%)

, BMY

Bristol-Myers

$60.86

-1.13 (-1.82%)

04:55
11/12/17
11/12
04:55
11/12/17
04:55
Conference/Events
Society for Immunotherapy of Cancer to hold annual meeting »

32nd Annual Meeting of…

CRIS

Curis

$1.23

-0.12 (-8.89%)

BMY

Bristol-Myers

$60.86

-1.13 (-1.82%)

CLLS

Cellectis

$25.06

-0.58 (-2.26%)

CRSP

Crispr Therapeutics

$17.45

0.5 (2.95%)

JNCE

Jounce Therapeutics

$14.77

0.24 (1.65%)

NKTR

Nektar

$32.50

0.76 (2.39%)

SNDX

Syndax

$10.11

0.09 (0.90%)

IDRA

Idera Pharmaceuticals

$2.11

0.09 (4.46%)

FPRX

Five Prime

$28.83

1.06 (3.82%)

NVS

Novartis

$82.38

-0.1 (-0.12%)

OMED

OncoMed

$4.87

0.14 (2.96%)

DNA

Bought by RHHBY

BAYRY

Bayer

$32.05

-0.211 (-0.65%)

AZN

AstraZeneca

$32.91

-0.2 (-0.60%)

ARRY

Array BioPharma

$11.00

0.18 (1.66%)

TSRO

Tesaro

$91.09

0.08 (0.09%)

XNCR

Xencor

$21.03

1.07 (5.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 16

    Nov

  • 28

    Nov

  • 29

    Nov

  • 30

    Nov

  • 04

    Dec

  • 06

    Dec

  • 09

    Dec

  • 14

    Dec

  • 05

    Mar

  • 17

    May

  • 30

    Jun

  • 30

    Jun

Over a week ago
CRIS

Curis

$1.23

-0.12 (-8.89%)

, BMY

Bristol-Myers

$60.86

-1.13 (-1.82%)

04:55
11/11/17
11/11
04:55
11/11/17
04:55
Conference/Events
Society for Immunotherapy of Cancer to hold annual meeting »

32nd Annual Meeting of…

CRIS

Curis

$1.23

-0.12 (-8.89%)

BMY

Bristol-Myers

$60.86

-1.13 (-1.82%)

CLLS

Cellectis

$25.06

-0.58 (-2.26%)

CRSP

Crispr Therapeutics

$17.45

0.5 (2.95%)

JNCE

Jounce Therapeutics

$14.77

0.24 (1.65%)

NKTR

Nektar

$32.50

0.76 (2.39%)

SNDX

Syndax

$10.11

0.09 (0.90%)

IDRA

Idera Pharmaceuticals

$2.11

0.09 (4.46%)

FPRX

Five Prime

$28.83

1.06 (3.82%)

NVS

Novartis

$82.38

-0.1 (-0.12%)

OMED

OncoMed

$4.87

0.14 (2.96%)

DNA

Bought by RHHBY

BAYRY

Bayer

$32.05

-0.211 (-0.65%)

AZN

AstraZeneca

$32.91

-0.2 (-0.60%)

ARRY

Array BioPharma

$11.00

0.18 (1.66%)

TSRO

Tesaro

$91.09

0.08 (0.09%)

XNCR

Xencor

$21.03

1.07 (5.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 11

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 16

    Nov

  • 28

    Nov

  • 29

    Nov

  • 30

    Nov

  • 04

    Dec

  • 06

    Dec

  • 09

    Dec

  • 14

    Dec

  • 05

    Mar

  • 17

    May

  • 30

    Jun

  • 30

    Jun

NVS

Novartis

$82.38

-0.1 (-0.12%)

17:54
11/10/17
11/10
17:54
11/10/17
17:54
Hot Stocks
Novartis reports further 'positive' results from brolucizumab trials »

Novartis announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 30

    Nov

  • 04

    Dec

  • 06

    Dec

  • 09

    Dec

  • 17

    May

CRIS

Curis

$1.35

0.01 (0.75%)

, BMY

Bristol-Myers

$61.99

-0.59 (-0.94%)

04:55
11/10/17
11/10
04:55
11/10/17
04:55
Conference/Events
Society for Immunotherapy of Cancer to hold annual meeting »

32nd Annual Meeting of…

CRIS

Curis

$1.35

0.01 (0.75%)

BMY

Bristol-Myers

$61.99

-0.59 (-0.94%)

CLLS

Cellectis

$25.64

-0.03 (-0.12%)

CRSP

Crispr Therapeutics

$16.95

-0.99 (-5.52%)

JNCE

Jounce Therapeutics

$14.53

0.08 (0.55%)

NKTR

Nektar

$31.74

1.44 (4.75%)

SNDX

Syndax

$10.02

0.09 (0.91%)

IDRA

Idera Pharmaceuticals

$2.02

0.25 (14.12%)

FPRX

Five Prime

$27.77

-2.67 (-8.77%)

NVS

Novartis

$82.48

-0.46 (-0.55%)

OMED

OncoMed

$4.73

0.24 (5.35%)

DNA

Bought by RHHBY

BAYRY

Bayer

$32.27

-0.905 (-2.73%)

AZN

AstraZeneca

$33.11

-0.22 (-0.66%)

ARRY

Array BioPharma

$10.82

-0.35 (-3.13%)

TSRO

Tesaro

$91.01

-7.43 (-7.55%)

XNCR

Xencor

$19.96

-0.56 (-2.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Nov

  • 10

    Nov

  • 11

    Nov

  • 11

    Nov

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 16

    Nov

  • 28

    Nov

  • 29

    Nov

  • 30

    Nov

  • 04

    Dec

  • 06

    Dec

  • 09

    Dec

  • 14

    Dec

  • 05

    Mar

  • 17

    May

  • 30

    Jun

  • 30

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.